Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription corepressor activity	TRERF1 HIPK3 NCOR1 NCOR2 HIPK2 TCF25 BCOR	1.04e-05	229	66	7	GO:0003714
GeneOntologyMolecularFunction	transcription coregulator activity	TRERF1 HIPK3 NCOR1 NCOR2 DYRK1A HIPK2 TCF25 BCOR MED12	9.22e-05	562	66	9	GO:0003712
GeneOntologyMolecularFunction	protein tyrosine kinase activity	HIPK3 SCYL1 DYRK1A HIPK2 TTK	1.18e-04	145	66	5	GO:0004713
GeneOntologyMolecularFunction	protein serine kinase activity	HIPK3 TNNI3K MINK1 DYRK1A HIPK2 SIK3 TTK	1.92e-04	363	66	7	GO:0106310
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	HIPK3 TNNI3K MINK1 DYRK1A HIPK2 SIK3 TTK	6.62e-04	446	66	7	GO:0004674
GeneOntologyMolecularFunction	beta-catenin binding	DLG5 PTPRK NUMB MED12	6.71e-04	120	66	4	GO:0008013
GeneOntologyMolecularFunction	protein kinase activity	HIPK3 TNNI3K MINK1 SCYL1 DYRK1A HIPK2 SIK3 TTK	7.86e-04	600	66	8	GO:0004672
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine phosphatase activity	PTPRK PTPRM	1.42e-03	17	66	2	GO:0005001
GeneOntologyMolecularFunction	transmembrane receptor protein phosphatase activity	PTPRK PTPRM	1.42e-03	17	66	2	GO:0019198
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	HIPK3 TNNI3K MINK1 SCYL1 DYRK1A HIPK2 SIK3 TTK	2.27e-03	709	66	8	GO:0016773
GeneOntologyMolecularFunction	tau-protein kinase activity	DYRK1A SIK3	2.38e-03	22	66	2	GO:0050321
GeneOntologyMolecularFunction	nuclear retinoid X receptor binding	NCOR1 NCOR2	2.60e-03	23	66	2	GO:0046965
GeneOntologyMolecularFunction	nuclear receptor binding	TRERF1 NCOR1 NCOR2 MED12	3.42e-03	187	66	4	GO:0016922
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	HIPK3 PARP11 TNNI3K MINK1 SCYL1 DYRK1A HIPK2 SIK3 TTK	3.58e-03	938	66	9	GO:0016772
GeneOntologyMolecularFunction	kinase activity	HIPK3 TNNI3K MINK1 SCYL1 DYRK1A HIPK2 SIK3 TTK	3.58e-03	764	66	8	GO:0016301
Domain	N-CoR_GPS2_interact	NCOR1 NCOR2	1.27e-05	2	67	2	IPR031557
Domain	GPS2_interact	NCOR1 NCOR2	1.27e-05	2	67	2	PF15784
Domain	SANT_dom	TRERF1 NCOR1 NCOR2	1.08e-04	26	67	3	IPR017884
Domain	ConA-like_dom	FAT1 PTPRK PTPRM PAPPA CLSTN2 RYR2	1.33e-04	219	67	6	IPR013320
Domain	SANT	TRERF1 NCOR1 NCOR2	1.36e-04	28	67	3	PS51293
Domain	Myb_DNA-binding	TRERF1 NCOR1 NCOR2	2.66e-04	35	67	3	PF00249
Domain	Ser/Thr_kinase_AS	HIPK3 TNNI3K MINK1 DYRK1A HIPK2 SIK3 TTK	2.86e-04	357	67	7	IPR008271
Domain	PROTEIN_KINASE_ST	HIPK3 TNNI3K MINK1 DYRK1A HIPK2 SIK3 TTK	3.11e-04	362	67	7	PS00108
Domain	MYB_LIKE	TRERF1 NCOR1 NCOR2	3.40e-04	38	67	3	PS50090
Domain	Prot_kinase_dom	HIPK3 TNNI3K MINK1 SCYL1 DYRK1A HIPK2 SIK3 TTK	3.51e-04	489	67	8	IPR000719
Domain	PROTEIN_KINASE_DOM	HIPK3 TNNI3K MINK1 SCYL1 DYRK1A HIPK2 SIK3 TTK	3.70e-04	493	67	8	PS50011
Domain	Protein_kinase_ATP_BS	HIPK3 TNNI3K MINK1 DYRK1A HIPK2 SIK3 TTK	4.09e-04	379	67	7	IPR017441
Domain	Pkinase	HIPK3 MINK1 SCYL1 DYRK1A HIPK2 SIK3 TTK	4.22e-04	381	67	7	PF00069
Domain	Kinase-like_dom	HIPK3 TNNI3K MINK1 SCYL1 DYRK1A HIPK2 SIK3 TTK	6.92e-04	542	67	8	IPR011009
Domain	SANT	TRERF1 NCOR1 NCOR2	7.67e-04	50	67	3	SM00717
Domain	SANT/Myb	TRERF1 NCOR1 NCOR2	8.60e-04	52	67	3	IPR001005
Domain	PROTEIN_KINASE_ATP	HIPK3 TNNI3K MINK1 DYRK1A HIPK2 SIK3 TTK	1.26e-03	459	67	7	PS00107
Domain	MAM_1	PTPRK PTPRM	1.47e-03	16	67	2	PS00740
Domain	MAM	PTPRK PTPRM	1.67e-03	17	67	2	SM00137
Domain	S_TKc	HIPK3 MINK1 DYRK1A HIPK2 SIK3 TTK	1.80e-03	359	67	6	SM00220
Domain	MAM	PTPRK PTPRM	1.87e-03	18	67	2	PF00629
Domain	MAM_dom	PTPRK PTPRM	1.87e-03	18	67	2	IPR000998
Domain	MAM_2	PTPRK PTPRM	1.87e-03	18	67	2	PS50060
Domain	-	FAT1 PAPPA CLSTN2	4.83e-03	95	67	3	2.60.120.200
Domain	CARD	DLG5 APAF1	5.51e-03	31	67	2	IPR001315
Domain	CARD	DLG5 APAF1	6.23e-03	33	67	2	PS50209
Domain	PTPc	PTPRK PTPRM	7.38e-03	36	67	2	SM00194
Domain	TYR_PHOSPHATASE_PTP	PTPRK PTPRM	8.62e-03	39	67	2	PS50055
Domain	PTPase_domain	PTPRK PTPRM	9.50e-03	41	67	2	IPR000242
Domain	Y_phosphatase	PTPRK PTPRM	9.50e-03	41	67	2	PF00102
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2	NCOR1 NCOR2 RBFOX1 HIPK2	6.08e-05	63	48	4	M27862
Pathway	WP_DELTANOTCH_SIGNALING_PATHWAY	HIVEP3 NCOR1 NCOR2 NUMB	1.70e-04	82	48	4	MM15922
Pathway	REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY	NCOR1 NCOR2 HIPK2	1.71e-04	32	48	3	M27900
Pathway	REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX	NCOR1 NCOR2	2.36e-04	7	48	2	M27899
Pathway	REACTOME_STIMULI_SENSING_CHANNELS	SLC9B1 TRPV4 ASIC4 RYR2	3.51e-04	99	48	4	MM14910
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS	NCOR1 NCOR2	4.03e-04	9	48	2	M29809
Pathway	REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS	NCOR2 PHC3 HIPK2	4.45e-04	44	48	3	M27295
Pathway	REACTOME_STIMULI_SENSING_CHANNELS	SLC9B1 TRPV4 ASIC4 RYR2	4.56e-04	106	48	4	M27200
Pathway	REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME	NCOR1 NCOR2	8.65e-04	13	48	2	M29766
Pubmed	Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK.	NCOR1 NCOR2 BCOR	2.73e-08	4	67	3	15878880
Pubmed	Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation.	HIPK3 DYRK1A HIPK2	2.73e-08	4	67	3	34785661
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TRERF1 NCOR1 NCOR2 ATXN2 PRRC2C SVIL MINK1 DYRK1A LRP1 QSER1 SIK3 BCOR PREPL	3.30e-08	963	67	13	28671696
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TRERF1 TET2 NCOR1 NCOR2 PHC3 LRP1 BCOR RFX1 MED12	1.11e-07	418	67	9	34709266
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	HIPK3 NCOR2 RBL2 MINK1 RBFOX1 SCYL1 DYRK1A HIPK2 NUMB SIK3 TTK LYST	1.53e-07	910	67	12	36736316
Pubmed	A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene.	NCOR1 NCOR2 BCOR	3.80e-07	8	67	3	19491398
Pubmed	Interaction network of human early embryonic transcription factors.	TRERF1 TET2 NCOR1 NCOR2 TAF3 QSER1 BCOR MED12	3.86e-07	351	67	8	38297188
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	DLG5 PRRC2C SCYL1 QSER1 BCOR TTK MED12	4.41e-07	242	67	7	34011540
Pubmed	Human transcription factor protein interaction networks.	TRERF1 TET2 NCOR1 NCOR2 PHC3 FAT1 TAF3 ATXN2 PRRC2C SVIL HIPK2 QSER1 BCOR RFX1	4.66e-07	1429	67	14	35140242
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TET2 DLG5 PRRC2C SYDE2 SVIL MINK1 DYRK1A NUMB SIK3 TTK LYST	7.30e-07	861	67	11	36931259
Pubmed	BCoR, a novel corepressor involved in BCL-6 repression.	NCOR1 NCOR2 BCOR	8.12e-07	10	67	3	10898795
Pubmed	Transcriptional cofactors exhibit differential preference toward peroxisome proliferator-activated receptors alpha and delta in uterine cells.	NCOR1 NCOR2 PEBP1	8.12e-07	10	67	3	15001550
Pubmed	The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation.	NCOR1 NCOR2 BCOR	1.12e-06	11	67	3	23658227
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	NCOR1 NCOR2 DLG5 SVIL LRP1 BCOR	1.54e-06	184	67	6	32908313
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TRERF1 NCOR1 NCOR2 PHC3 ATXN2 LITAF SCYL1 NUMB	1.76e-06	430	67	8	35044719
Pubmed	Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions.	TRERF1 NCOR1 NCOR2 C7orf25 NUMB	2.39e-06	110	67	5	37219487
Pubmed	NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming.	NCOR1 NCOR2	3.66e-06	2	67	2	29531310
Pubmed	CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.	NCOR1 NCOR2	3.66e-06	2	67	2	27733359
Pubmed	A novel protein with RNA-binding motifs interacts with ataxin-2.	ATXN2 RBFOX1	3.66e-06	2	67	2	10814712
Pubmed	Identification and expression of a mouse ortholog of A2BP1.	ATXN2 RBFOX1	3.66e-06	2	67	2	11471052
Pubmed	Corepressors (NCoR and SMRT) as well as coactivators are recruited to positively regulated 1α,25-dihydroxyvitamin D3-responsive genes.	NCOR1 NCOR2	3.66e-06	2	67	2	22944139
Pubmed	Determinants of receptor tyrosine phosphatase homophilic adhesion: Structural comparison of PTPRK and PTPRM extracellular domains.	PTPRK PTPRM	3.66e-06	2	67	2	36436563
Pubmed	Aberrant corepressor interactions implicated in PML-RAR(alpha) and PLZF-RAR(alpha) leukemogenesis reflect an altered recruitment and release of specific NCoR and SMRT splice variants.	NCOR1 NCOR2	3.66e-06	2	67	2	21131350
Pubmed	Regulation of corepressor alternative mRNA splicing by hormonal and metabolic signaling.	NCOR1 NCOR2	3.66e-06	2	67	2	26166430
Pubmed	Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways.	NCOR1 NCOR2	3.66e-06	2	67	2	19299558
Pubmed	Unique forms of human and mouse nuclear receptor corepressor SMRT.	NCOR1 NCOR2	3.66e-06	2	67	2	10077563
Pubmed	Nuclear Receptor Corepressors NCOR1 and SMRT Regulate Metabolism via Intestinal Regulation of Carbohydrate Transport.	NCOR1 NCOR2	3.66e-06	2	67	2	39106294
Pubmed	Bcor insufficiency promotes initiation and progression of myelodysplastic syndrome.	TET2 BCOR	3.66e-06	2	67	2	30228234
Pubmed	Homophilic interactions mediated by receptor tyrosine phosphatases mu and kappa. A critical role for the novel extracellular MAM domain.	PTPRK PTPRM	3.66e-06	2	67	2	7782276
Pubmed	Evolution of NCoR-1 and NCoR-2 corepressor alternative mRNA splicing in placental mammals.	NCOR1 NCOR2	3.66e-06	2	67	2	31208445
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TRERF1 TET2 NCOR1 NCOR2 ATXN2 PEBP1 PRRC2C QSER1 BCOR RFX1 MED12	7.85e-06	1103	67	11	34189442
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	HIPK3 TET2 NCOR1 BNC2 NCOR2 SVIL MINK1 APOBEC1	8.87e-06	536	67	8	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	HIPK3 TET2 NCOR1 BNC2 NCOR2 SVIL MINK1 APOBEC1	9.12e-06	538	67	8	10512203
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOR1 TAF3 PRRC2C NUMB QSER1 BCOR RFX1 MED12	1.06e-05	549	67	8	38280479
Pubmed	Functional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus.	NCOR1 NCOR2	1.10e-05	3	67	2	16030140
Pubmed	Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor.	NCOR1 NCOR2	1.10e-05	3	67	2	19098224
Pubmed	The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.	NCOR1 NCOR2	1.10e-05	3	67	2	16373395
Pubmed	A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters.	NCOR2 BCOR	1.10e-05	3	67	2	23911289
Pubmed	Nuclear corepressor SMRT is a strong regulator of body weight independently of its ability to regulate thyroid hormone action.	NCOR1 NCOR2	1.10e-05	3	67	2	31404087
Pubmed	Regulated clearance of histone deacetylase 3 protects independent formation of nuclear receptor corepressor complexes.	NCOR1 NCOR2	1.10e-05	3	67	2	22337871
Pubmed	Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo.	NCOR1 NCOR2	1.10e-05	3	67	2	23292142
Pubmed	Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.	NCOR1 NCOR2	1.10e-05	3	67	2	15016838
Pubmed	Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor.	NCOR1 NCOR2	1.10e-05	3	67	2	24268577
Pubmed	Nuclear Receptor CoRepressors, NCOR1 and SMRT, are required for maintaining systemic metabolic homeostasis.	NCOR1 NCOR2	1.10e-05	3	67	2	34390859
Pubmed	Oligomerization of ETO is obligatory for corepressor interaction.	NCOR1 NCOR2	1.10e-05	3	67	2	11113190
Pubmed	RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding.	NCOR1 NCOR2	1.10e-05	3	67	2	12011091
Pubmed	EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.	NCOR1 NCOR2	1.10e-05	3	67	2	21518914
Pubmed	Knockdown of circ_HIPK3 inhibits tumorigenesis of hepatocellular carcinoma via the miR-582-3p/DLX2 axis.	HIPK3 DLX2	1.10e-05	3	67	2	32977948
Pubmed	Update on the Regulation of HIPK1, HIPK2 and HIPK3 Protein Kinases by microRNAs.	HIPK3 HIPK2	1.10e-05	3	67	2	29793420
Pubmed	Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.	NCOR1 NCOR2	1.10e-05	3	67	2	15802375
Pubmed	SMRT and NCoR1 fine-tune inflammatory versus tolerogenic balance in dendritic cells by differentially regulating STAT3 signaling.	NCOR1 NCOR2	1.10e-05	3	67	2	36238311
Pubmed	The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD.	NCOR1 NCOR2	1.10e-05	3	67	2	10406466
Pubmed	Nuclear corepressors NCOR1/NCOR2 regulate B cell development, maintain genomic integrity and prevent transformation.	NCOR1 NCOR2	1.10e-05	3	67	2	36316474
Pubmed	The functional relationship between co-repressor N-CoR and SMRT in mediating transcriptional repression by thyroid hormone receptor alpha.	NCOR1 NCOR2	1.10e-05	3	67	2	18052923
Pubmed	The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.	NCOR1 NCOR2	1.10e-05	3	67	2	11997503
Pubmed	Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor.	NCOR1 NCOR2	1.10e-05	3	67	2	18852122
Pubmed	cDNAs with long CAG trinucleotide repeats from human brain.	NCOR2 ATXN2 MED12	1.18e-05	23	67	3	9225980
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TRERF1 TET2 NCOR1 QSER1 BCOR MED12	1.33e-05	268	67	6	33640491
Pubmed	BCOR modulates transcriptional activity of a subset of glucocorticoid receptor target genes involved in cell growth and mobility.	NCOR1 NCOR2 BCOR	1.34e-05	24	67	3	33722704
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TRERF1 NCOR1 NCOR2 PHC3 TAF3 SVIL MINK1 BCOR RFX1	1.73e-05	774	67	9	15302935
Pubmed	Functional proteomics mapping of a human signaling pathway.	HIPK3 NCOR1 NCOR2 LITAF LRP1 PAPPA RFX1 RYR2	1.79e-05	591	67	8	15231748
Pubmed	NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.	TET2 NCOR2 QSER1	1.93e-05	27	67	3	23395962
Pubmed	MicroRNAs are mediators of androgen action in prostate and muscle.	NCOR1 NCOR2	2.19e-05	4	67	2	21048966
Pubmed	Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO.	NCOR1 NCOR2	2.19e-05	4	67	2	9819405
Pubmed	Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers.	NCOR1 NCOR2	2.19e-05	4	67	2	18362166
Pubmed	Silencing mediator for retinoid and thyroid hormone receptor and nuclear receptor corepressor attenuate transcriptional activation by the beta-catenin-TCF4 complex.	NCOR1 NCOR2	2.19e-05	4	67	2	18632669
Pubmed	Estrogenic induction of spermatogenesis in the hypogonadal mouse.	HIPK3 HIPK2	2.19e-05	4	67	2	10919273
Pubmed	Dichotomous engagement of HDAC3 activity governs inflammatory responses.	NCOR1 NCOR2	2.19e-05	4	67	2	32760002
Pubmed	A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones.	NCOR1 NCOR2	2.19e-05	4	67	2	19147680
Pubmed	A cell type-specific expression map of NCoR1 and SMRT transcriptional co-repressors in the mouse brain.	NCOR1 NCOR2	2.19e-05	4	67	2	32072640
Pubmed	NCoR1 and SMRT play unique roles in thyroid hormone action in vivo.	NCOR1 NCOR2	2.19e-05	4	67	2	25421714
Pubmed	FBI-1 functions as a novel AR co-repressor in prostate cancer cells.	NCOR1 NCOR2	2.19e-05	4	67	2	20812024
Pubmed	Direct association between the CREB-binding protein (CBP) and nuclear receptor corepressor (N-CoR).	NCOR1 NCOR2	2.19e-05	4	67	2	17073437
Pubmed	The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.	NCOR1 NCOR2	2.19e-05	4	67	2	16024608
Pubmed	The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3.	NCOR1 NCOR2	2.19e-05	4	67	2	11509652
Pubmed	Differential expression of MAM-subfamily protein tyrosine phosphatases during mouse development.	PTPRK PTPRM	2.19e-05	4	67	2	9510027
Pubmed	The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity.	NCOR1 NCOR2	2.19e-05	4	67	2	19211732
Pubmed	Transcriptional integration of TLR2 and TLR4 signaling at the NCoR derepression checkpoint.	NCOR1 NCOR2	2.19e-05	4	67	2	19595715
Pubmed	The adaptor protein DCAF7 mediates the interaction of the adenovirus E1A oncoprotein with the protein kinases DYRK1A and HIPK2.	DYRK1A HIPK2	2.19e-05	4	67	2	27307198
Pubmed	Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1.	NCOR1 NCOR2	2.19e-05	4	67	2	16121196
Pubmed	A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation.	NCOR1 NCOR2	2.19e-05	4	67	2	12840002
Pubmed	Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases (HIPK).	HIPK3 HIPK2	2.19e-05	4	67	2	25630557
Pubmed	The physical and genetic map surrounding the Lyst gene on mouse chromosome 13.	LYST RYR2	2.19e-05	4	67	2	9070932
Pubmed	Nuclear receptor coregulator SNP discovery and impact on breast cancer risk.	NCOR1 NCOR2	2.19e-05	4	67	2	20003447
Pubmed	A SPRY1 domain cardiac ryanodine receptor variant associated with short-coupled torsade de pointes.	TNNI3K RYR2	2.19e-05	4	67	2	33664309
Pubmed	A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor.	NCOR1 NCOR2	2.19e-05	4	67	2	20543827
Pubmed	GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression.	NCOR1 NCOR2	2.19e-05	4	67	2	26712002
Pubmed	Glucocorticoid-induced tethered transrepression requires SUMOylation of GR and formation of a SUMO-SMRT/NCoR1-HDAC3 repressing complex.	NCOR1 NCOR2	2.19e-05	4	67	2	26712006
Pubmed	SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron.	NCOR1 NCOR2 DLX2	2.41e-05	29	67	3	17928865
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NCOR1 NCOR2 ATXN2 PEBP1 PRRC2C QSER1 BCOR	2.85e-05	457	67	7	32344865
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOR1 NCOR2 SIK3 BCOR RFX1 PREPL FER1L6 RYR2	3.09e-05	638	67	8	31182584
Pubmed	Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor.	NCOR1 NCOR2	3.64e-05	5	67	2	7566114
Pubmed	ERbeta Binds N-CoR in the Presence of Estrogens via an LXXLL-like Motif in the N-CoR C-terminus.	NCOR1 NCOR2	3.64e-05	5	67	2	12904255
Pubmed	Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma.	NCOR1 NCOR2	3.64e-05	5	67	2	15175761
Pubmed	Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor.	NCOR1 NCOR2	3.64e-05	5	67	2	14593076
Pubmed	Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.	NCOR1 NCOR2	3.64e-05	5	67	2	11865059
Pubmed	Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells.	NCOR1 NCOR2	3.64e-05	5	67	2	21088000
Pubmed	Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells.	NCOR1 NCOR2	3.64e-05	5	67	2	23703729
Pubmed	Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.	NCOR1 NCOR2	3.64e-05	5	67	2	15531890
Pubmed	Tet1 and Tet2 maintain mesenchymal stem cell homeostasis via demethylation of the P2rX7 promoter.	TET2 LYST	3.64e-05	5	67	2	29858571
Interaction	FEV interactions	NCOR1 NCOR2 PHC3 TAF3 QSER1 BCOR RFX1	4.47e-06	203	66	7	int:FEV
Interaction	SP7 interactions	TRERF1 TET2 NCOR1 NCOR2 DLX2 QSER1 BCOR RFX1	6.57e-06	304	66	8	int:SP7
Interaction	NUP35 interactions	HIVEP3 NCOR1 NCOR2 ATXN2 PEBP1 PRRC2C DYRK1A QSER1 BCOR	9.51e-06	424	66	9	int:NUP35
Interaction	EGR2 interactions	TRERF1 TET2 NCOR1 NCOR2 QSER1 BCOR	2.04e-05	171	66	6	int:EGR2
Interaction	DCAF7 interactions	NCOR1 ATXN2 RBL2 SVIL DYRK1A HIPK2 NUMB BCOR	2.61e-05	368	66	8	int:DCAF7
Interaction	ALG13 interactions	NCOR1 NCOR2 ATXN2 PRRC2C RBFOX1 BCOR	2.99e-05	183	66	6	int:ALG13
Interaction	PAX8 interactions	TET2 NCOR1 NCOR2 QSER1 BCOR	3.17e-05	111	66	5	int:PAX8
Interaction	TBR1 interactions	TET2 NCOR1 NCOR2 QSER1 BCOR	3.45e-05	113	66	5	int:TBR1
Interaction	FHL2 interactions	NCOR1 NCOR2 PHC3 PRRC2C DYRK1A HIPK2 QSER1 RFX1	4.40e-05	396	66	8	int:FHL2
Interaction	SKIL interactions	HIPK3 NCOR1 NCOR2 LRP1 PAPPA	4.42e-05	119	66	5	int:SKIL
Interaction	GCM1 interactions	TET2 NCOR1 NCOR2 BCOR	7.30e-05	68	66	4	int:GCM1
Interaction	ERG interactions	TET2 NCOR1 NCOR2 HIPK2 QSER1 BCOR	8.96e-05	223	66	6	int:ERG
Interaction	TNNI3 interactions	TNNI3K PAPPA LYST	1.04e-04	28	66	3	int:TNNI3
Interaction	GUSBP5 interactions	NCOR1 NCOR2 ATXN2 BCOR	1.07e-04	75	66	4	int:GUSBP5
Interaction	SOX6 interactions	NCOR1 NCOR2 PRRC2C QSER1 BCOR	1.64e-04	157	66	5	int:SOX6
Interaction	QPRT interactions	NCOR1 NCOR2 PRRC2C BCOR	1.66e-04	84	66	4	int:QPRT
Interaction	CRX interactions	TRERF1 TET2 NCOR2 RBFOX1 QSER1 MED12	1.82e-04	254	66	6	int:CRX
Interaction	SOX5 interactions	NCOR1 NCOR2 PRRC2C QSER1 BCOR	1.90e-04	162	66	5	int:SOX5
Interaction	NUP43 interactions	NCOR1 NCOR2 PHC3 TAF3 PRRC2C CLSTN2 BCOR MED12 RYR2	1.92e-04	625	66	9	int:NUP43
Interaction	SAP30 interactions	TET2 NCOR1 NCOR2 PHC3 LYST	2.19e-04	167	66	5	int:SAP30
Interaction	KDM1A interactions	ZNF280A TRERF1 TET2 NCOR1 NCOR2 PHC3 DLG5 LRP1 BCOR RFX1 MED12	2.21e-04	941	66	11	int:KDM1A
Interaction	CNOT2 interactions	NCOR1 NCOR2 PRRC2C MINK1 DYRK1A	2.94e-04	178	66	5	int:CNOT2
Cytoband	12q24.1	ATXN2 TRPV4	2.18e-04	15	67	2	12q24.1
Cytoband	4q24	TET2 SLC9B1	1.14e-03	34	67	2	4q24
Cytoband	11p13	HIPK3 QSER1	3.07e-03	56	67	2	11p13
Cytoband	Ensembl 112 genes in cytogenetic band chr12q24	NCOR2 ATXN2 PEBP1 TRPV4	3.22e-03	415	67	4	chr12q24
Cytoband	Ensembl 112 genes in cytogenetic band chr4q24	TET2 SLC9B1	3.40e-03	59	67	2	chr4q24
Cytoband	Ensembl 112 genes in cytogenetic band chr11p13	HIPK3 QSER1	4.11e-03	65	67	2	chr11p13
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOR2 ATXN2 MED12	2.59e-05	25	42	3	775
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	TRERF1 NCOR1 NCOR2	2.52e-04	53	42	3	532
GeneFamily	Cadherin related	FAT1 CLSTN2	7.01e-04	17	42	2	24
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRK PTPRM	1.08e-03	21	42	2	813
Coexpression	GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN	HIPK3 SYDE2 SVIL DYRK1A SIK3 BCOR RFX1	2.37e-07	167	67	7	M361
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	HIPK3 NCOR1 PHC3 ATXN2 PEBP1 RBL2 HIPK2 SIK3 RFX1 ANGPTL1 ITGB8	5.87e-06	807	67	11	M16651
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	BNC2 PTPRK PTPRM SVIL CLSTN2 ITGB8	5.98e-06	176	67	6	M39223
Coexpression	GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN	PRDM10 PTPRK C7orf25 DYRK1A APOBEC1 LYST	1.24e-05	200	67	6	M5975
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	HIVEP3 PTPRM SVIL DYRK1A HIPK2	2.70e-05	137	67	5	M39241
Coexpression	NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP	HIPK3 NCOR1 MINK1 APAF1 HIPK2 TMEM184C LYST PREPL	2.89e-05	477	67	8	M40930
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	NCOR2 DLG5 FAT1 PEBP1 RBL2 SVIL RBFOX1 SHISA2 BCOR TTK ITGB8	4.65e-05	1009	67	11	M157
Coexpression	RODRIGUES_THYROID_CARCINOMA_DN	BNC2 PTPRK HIPK2 ITGB8	4.82e-05	78	67	4	M9814
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NCOR2 FAT1 PTPRK PTPRM ATXN2 PRRC2C DYRK1A NUMB SIK3 TTK	6.02e-05	856	67	10	M4500
Coexpression	GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP	SYDE2 SIK3 BCOR RFX1 RYR2	6.75e-05	166	67	5	M344
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	TET2 NCOR1 PHC3 PRDM10 TCF25	6.75e-05	166	67	5	M6826
Coexpression	LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2	BNC2 SVIL RBFOX1 ITGB8	7.07e-05	86	67	4	M39248
Coexpression	GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN	HIPK2 NUMB QSER1 BCOR ANGPTL1	8.66e-05	175	67	5	M2940
Coexpression	DE_YY1_TARGETS_DN	NCOR1 RBL2 HIPK2 TTK	9.59e-05	93	67	4	M3278
Coexpression	GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN	PHC3 TAF3 PTPRK LYST SLC25A37	1.58e-04	199	67	5	M9236
Coexpression	MARTIN_INTERACT_WITH_HDAC	NCOR1 NCOR2 BCOR	1.59e-04	41	67	3	M15154
Coexpression	GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_UP	NXPE4 SVIL MINK1 APOBEC1 BCOR	1.62e-04	200	67	5	M5997
Coexpression	GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_DN	LITAF MINK1 APAF1 SIK3 AMTN	1.62e-04	200	67	5	M9352
Coexpression	GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP	NCOR1 FRRS1 LRP1 APOBEC1 QSER1	1.62e-04	200	67	5	M6262
Coexpression	GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP	DLG5 PTPRK CD22 RNF44 LYST	1.62e-04	200	67	5	M4440
Coexpression	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	DLG5 SHISA2 BCOR ITGB8 SLC25A37	1.86e-04	206	67	5	M14134
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	TET2 FAT1 RBFOX1 SIK3 ITGB8	2.12e-04	212	67	5	M39221
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP	HIPK3 NCOR1 CD22 APAF1 SIK3	2.47e-04	219	67	5	M41199
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TRERF1 PRDM10 CARF ITGB8 IQUB RYR2	2.05e-07	168	67	6	c66a61d3ec711796313a2c6d2dc39aedbfc20afd
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TRERF1 PRDM10 CARF ITGB8 IQUB RYR2	2.05e-07	168	67	6	83b4f817d95daa15ae60668e789f97d8a3b2e6dd
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRERF1 BNC2 RBFOX1 LRP1 PAPPA RYR2	3.39e-07	183	67	6	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 FAT1 NUMB PAPPA CLSTN2 ITGB8	3.85e-07	187	67	6	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	RA-14._Fibroblast_III\|RA / Chamber and Cluster_Paper	BNC2 NCOR2 FAT1 LITAF PAPPA SIK3	4.09e-07	189	67	6	46e9a58aacd79db5a02898a8c7244e1884adcfd1
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 RBFOX1 LRP1 PAPPA ANGPTL1 RYR2	4.09e-07	189	67	6	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HIVEP3 BNC2 LRP1 PAPPA ITGB8 RYR2	4.22e-07	190	67	6	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	CTRL-Myeloid-Alveolar_Macrophage\|Myeloid / Disease state, Lineage and Cell class	PTPRM PEBP1 SVIL LRP1 HIPK2 ITGB8	4.63e-07	193	67	6	80871d963c23a6befe58e5e60b7f7d1a1b227ce2
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|368C / Donor, Lineage, Cell class and subclass (all cells)	PRDM10 CARF ITGB8 IQUB RYR2	5.48e-06	168	67	5	1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	PRDM10 CARF ITGB8 IQUB RYR2	5.48e-06	168	67	5	69f534de0f9a293047bea03cb1b78551087a8df5
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRERF1 BNC2 RBFOX1 LRP1 PAPPA	8.75e-06	185	67	5	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 FAT1 RBFOX1 CLSTN2 ITGB8	9.45e-06	188	67	5	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 FAT1 RBFOX1 CLSTN2 ITGB8	9.45e-06	188	67	5	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 FAT1 PTPRK CLSTN2 ITGB8	9.70e-06	189	67	5	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	RA-14._Fibroblast_III\|World / Chamber and Cluster_Paper	BNC2 FAT1 LITAF PAPPA SIK3	9.70e-06	189	67	5	b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b
ToppCell	COVID-19-kidney-PCT-S2\|kidney / Disease (COVID-19 only), tissue and cell type	BNC2 FAT1 PAPPA CLSTN2 ITGB8	9.70e-06	189	67	5	0be5c669b6b308bd98ddb70c84877c62a6244bbd
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	FAT1 SVIL RBFOX1 SIK3 RYR2	9.95e-06	190	67	5	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	COPD-Myeloid-Macrophage_Alveolar\|Myeloid / Disease state, Lineage and Cell class	PTPRM PEBP1 SVIL LRP1 ITGB8	9.95e-06	190	67	5	9fc763d65470ba8858b973689c4d4358faab7dd3
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 RBFOX1 LRP1 PAPPA RYR2	1.02e-05	191	67	5	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 FAT1 PTPRK CLSTN2 ITGB8	1.02e-05	191	67	5	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 PTPRK PTPRM SVIL SIK3	1.05e-05	192	67	5	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	COPD-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	HIVEP3 BNC2 LITAF HIPK2 LYST	1.07e-05	193	67	5	0020249fa71afb500af73700543bb6f349be6b10
ToppCell	LV-14._Fibroblast_III\|LV / Chamber and Cluster_Paper	BNC2 NCOR2 FAT1 TMEM184C PAPPA	1.10e-05	194	67	5	927c26aea0147f7a4b8fb3f192de4de263f1b978
ToppCell	CTRL-Myeloid-Alveolar_Macrophage\|CTRL / Disease state, Lineage and Cell class	PTPRM PEBP1 SVIL LRP1 HIPK2	1.10e-05	194	67	5	be69b20afa915978c4cf2feb0bb21ab7c1f301a5
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	HIVEP3 PTPRK PTPRM DYRK1A SIK3	1.16e-05	196	67	5	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRERF1 BNC2 TNNI3K CD22 ASIC4	1.19e-05	197	67	5	bed8a9b73af5caee51b1232b31c24a59353658df
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRERF1 BNC2 TNNI3K CD22 ASIC4	1.19e-05	197	67	5	b7d5073d44aa1e2cb83ea8d8104c5ed662665755
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 LRP1 NUMB LYST SLC25A37	1.21e-05	198	67	5	a77f3440d7fb6a50066abc7e9ad59e83798ef13d
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	HIPK3 BNC2 LITAF SVIL SIK3	1.21e-05	198	67	5	b8bd1ba268480f54451648e01631b615a3401144
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 LRP1 NUMB LYST SLC25A37	1.21e-05	198	67	5	d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b
ToppCell	critical\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CD22 LITAF NUMB LYST SLC25A37	1.24e-05	199	67	5	16c55cb8a0e740342009965f0eddfb0ed2858fab
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FAT1 PRDM10 PRRC2C ITGB8 UTP14C	1.24e-05	199	67	5	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	HIVEP3 LRP1 PAPPA ITGB8 RYR2	1.24e-05	199	67	5	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm\|6m / Sample Type, Dataset, Time_group, and Cell type.	HIPK3 SVIL RBFOX1 SHISA2 CLSTN2	1.27e-05	200	67	5	0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FAT1 SVIL DLX2 ASIC4	3.68e-05	124	67	4	36dfc702a570e1a1a6dde09f38badf9023ea7287
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MS4A8 CLSTN2 TTK FER1L6	4.99e-05	134	67	4	64979e1a056b7406e1be39c5ebe2f8d731ac3c17
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|GI_small-bowel / Manually curated celltypes from each tissue	DLG5 LITAF DLX2 LYST	5.13e-05	135	67	4	11a672ab6cba7026b8d81d8b216443cb88c0d47a
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FAT1 SVIL DLX2 ASIC4	5.75e-05	139	67	4	9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-like-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MS4A8 CLSTN2 TTK FER1L6	6.25e-05	142	67	4	5690eee2ce1ecd02e34eac4193578bd13c4228b9
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FAT1 SVIL DLX2 ASIC4	8.34e-05	153	67	4	9c6fce56300ba5053efda59a438d63a808c497c0
ToppCell	facs-MAT-Fat-24m-Myeloid-macrophage\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRERF1 FRRS1 MS4A8 APOBEC1	8.77e-05	155	67	4	d0c1608f8f6b6f4174e51d610501c707cba5e015
ToppCell	facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRM NXPE4 MINK1 SLC25A37	8.99e-05	156	67	4	5caefdc6cc86f2ac52abe8c8da821db14f476915
ToppCell	facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRM NXPE4 MINK1 SLC25A37	8.99e-05	156	67	4	758f57dc10fc5cad200bf5b310c10ec9b1405f23
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pappa_(ventral_GP_(vGP))--\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	TNNI3K PAPPA FER1L6	9.67e-05	59	67	3	22f5abf0b7fca1c9b7ce8d1f5e09eebad8937f11
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pappa_(ventral_GP_(vGP))\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	TNNI3K PAPPA FER1L6	9.67e-05	59	67	3	804f6ec763209b2513e7688925136033b41a7b61
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pappa_(ventral_GP_(vGP))-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	TNNI3K PAPPA FER1L6	9.67e-05	59	67	3	025a2df1825fbfa7f37764371dae9296cb9908b6
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	PRRC2C SYDE2 DLX2 ASIC4	9.68e-05	159	67	4	7f29f9dcf25ffa1822b137c571e9ac16defc6292
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1 MS4A8 TRPV4 SLC25A37	9.92e-05	160	67	4	56e6f4b82b5dc41c45f9d253c2db314a6f702b84
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1 MS4A8 TRPV4 SLC25A37	9.92e-05	160	67	4	bb1b966fb9e801db15e67d03e49db4609d6f935a
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1 MS4A8 TRPV4 SLC25A37	1.02e-04	161	67	4	60f433eab9d5531bdf6aa86b0265f20b866b904c
ToppCell	facs-Marrow-T_cells-18m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRM NXPE4 LRP1 MS4A8	1.07e-04	163	67	4	30cd95d4f37bd54c1fde54960cb005db58bdd30c
ToppCell	facs-Marrow-T_cells-18m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRM NXPE4 LRP1 MS4A8	1.07e-04	163	67	4	ab934cb986495adfc8dbe5a276577f2a8fb6ee03
ToppCell	droplet-Kidney-nan-24m-Myeloid-CD45____macrophage\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NXPE4 LRP1 MS4A8 APOBEC1	1.09e-04	164	67	4	d57faa4fce1f1e9a92aaf5cb920af99323252e4b
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CARF NUMB LYST SLC25A37	1.09e-04	164	67	4	f9a2cc12179d5621c9174ec01d7418a71edd28d1
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRERF1 BNC2 CD22 ASIC4	1.12e-04	165	67	4	37615622c736e43260c38016e7c9e565ac97a3e8
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRERF1 BNC2 CD22 ASIC4	1.12e-04	165	67	4	640bb71e74a61df2fcb01ceeabe4c493ef836b21
ToppCell	nucseq-Immune-Hematopoietic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRERF1 BNC2 CD22 ASIC4	1.12e-04	165	67	4	f3df74b5763130c71c0a482a3a23f6b22acc2892
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BNC2 FAT1 RBFOX1 ITGB8	1.20e-04	168	67	4	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PTPRM PRRC2C DLX2 ASIC4	1.22e-04	169	67	4	c135d7ae0490d0024e0f4bd8c4ad42f6674a61da
ToppCell	droplet-Marrow-BM-1m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NXPE4 LRP1 MS4A8 APOBEC1	1.22e-04	169	67	4	8066b4c02c97d00034802cff2b39799ef44cc904
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRDM10 NUMB PAPPA SHISA2	1.25e-04	170	67	4	50c6c571591aa4b218caefe5778c570c809f567e
ToppCell	COVID-19-lung-MAST\|lung / Disease (COVID-19 only), tissue and cell type	TRERF1 BNC2 CD22 ASIC4	1.25e-04	170	67	4	e90f18e5462381b38e918442b38b1c8105291908
ToppCell	droplet-Spleen-nan-21m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NXPE4 LRP1 MS4A8 AMTN	1.25e-04	170	67	4	03cb4e508356f85372a588c8d1c6babf2a012683
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRDM10 NUMB PAPPA SHISA2	1.25e-04	170	67	4	8fe32dcf924d5f6665f7febbc9647d96b1e96f06
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LITAF SVIL DLX2 ASIC4	1.25e-04	170	67	4	14aa86a4f526ed6986afcb28c49225522055550c
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRDM10 NUMB PAPPA SHISA2	1.25e-04	170	67	4	3232db50b1a40f861e981a1b9c9073b81af9f832
ToppCell	droplet-Spleen-nan-21m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NXPE4 LRP1 MS4A8 AMTN	1.28e-04	171	67	4	9498c35b2a2c3a339dc8c5d49c8ec20d8ad52753
ToppCell	droplet-Spleen-nan-21m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NXPE4 LRP1 MS4A8 AMTN	1.28e-04	171	67	4	db544252f98e073e5bb4bec4a110cd58e6434435
ToppCell	droplet-Marrow-nan-3m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1 MS4A8 APOBEC1 LYST	1.28e-04	171	67	4	992df143d76f9e7fb1997a8996f61e941f0f9d4f
ToppCell	10x5'-GI_small-bowel-Lymphocytic_NK\|GI_small-bowel / Manually curated celltypes from each tissue	BNC2 LITAF SVIL LYST	1.37e-04	174	67	4	09b216f07cffd3ea2149ea95ffb5cd7219b3a98c
ToppCell	droplet-Marrow-BM-30m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NXPE4 LRP1 MS4A8 APOBEC1	1.37e-04	174	67	4	118ba2729ecc6aa1bb8548f3cf537b3f9e902ef0
ToppCell	COVID-19-kidney-Podocyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FAT1 RBFOX1 SHISA2 ITGB8	1.40e-04	175	67	4	a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LITAF SVIL DLX2 ASIC4	1.43e-04	176	67	4	05ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCell	COVID-19-lung-MAST\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TRERF1 BNC2 CD22 ASIC4	1.43e-04	176	67	4	473c45a381ca109207d66ed1635668b391ea0e1f
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NCOR2 PRDM10 C7orf25 MS4A8	1.43e-04	176	67	4	90f8bb11f339f67f08692a0c33dd420f5cda2861
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BNC2 FAT1 RBFOX1 ITGB8	1.49e-04	178	67	4	544379f5a6145429762258d426b876bb36c112f5
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HIVEP3 BNC2 LRP1 RYR2	1.56e-04	180	67	4	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BNC2 FAT1 PAPPA ITGB8	1.56e-04	180	67	4	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	COVID-19-kidney-tDL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BNC2 FAT1 PAPPA ITGB8	1.56e-04	180	67	4	864c895b5eaedefae86f5829fa344f7b686fb59f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 PAPPA TRPV4 IQUB	1.56e-04	180	67	4	023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DMGDH HIPK2 CLSTN2 ITGB8	1.59e-04	181	67	4	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BNC2 CLSTN2 ANGPTL1 RYR2	1.59e-04	181	67	4	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	RBFOX1 TRPV4 BCOR RYR2	1.59e-04	181	67	4	c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 FAT1 RBFOX1 ITGB8	1.59e-04	181	67	4	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 FAT1 RBFOX1 ITGB8	1.59e-04	181	67	4	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DMGDH HIPK2 CLSTN2 ITGB8	1.63e-04	182	67	4	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FAT1 HIPK2 PAPPA RYR2	1.63e-04	182	67	4	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD22 PRRC2C TCF25 LYST	1.63e-04	182	67	4	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	Hippocampus-Neuronal-Inhibitory\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PTPRM PRRC2C DLX2 ASIC4	1.63e-04	182	67	4	b54ae650c04dfd0759c5f5e752b9bf684dd36516
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRERF1 BNC2 RBFOX1 PAPPA	1.66e-04	183	67	4	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	PTPRM SVIL RBFOX1 RYR2	1.70e-04	184	67	4	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	BNC2 SVIL PAPPA RYR2	1.73e-04	185	67	4	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PTPRK PTPRM ATXN2 LRP1	1.73e-04	185	67	4	1d874608aa2062024323512f68889219471b2f00
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	BNC2 HIPK2 ANGPTL1 RYR2	1.77e-04	186	67	4	7def03dd856b765bd3f493288641981c4f7fd26e
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PRRC2C LRP1 TCF25 RYR2	1.77e-04	186	67	4	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 PTPRK PAPPA ITGB8	1.77e-04	186	67	4	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	COVID-19-kidney-tDL\|kidney / Disease (COVID-19 only), tissue and cell type	BNC2 FAT1 PAPPA ITGB8	1.81e-04	187	67	4	d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FAT1 HIPK2 PAPPA CLSTN2	1.81e-04	187	67	4	c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCell	LV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	BNC2 NCOR2 FAT1 TMEM184C	1.88e-04	189	67	4	3922135d1f6fc768d71ba3b465585fead6ea68a8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 PAPPA CLSTN2 ITGB8	1.88e-04	189	67	4	204ab61ae606b2d9be0cb6bf6a83a011740693a8
Drug	Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; MCF7; HT_HG-U133A	HIVEP3 CD22 C7orf25 HIPK2 CLSTN2 SLC25A37 RYR2	1.65e-06	194	67	7	3404_UP
Drug	pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A	HIPK3 HIVEP3 ATXN2 CARF RBFOX1 DLX2 LYST	1.89e-06	198	67	7	7506_DN
Drug	CV-1	TRERF1 HIPK3 NCOR1 NCOR2 PHC3 SVIL MED12	3.07e-06	213	67	7	CID000130105
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	DLG5 PRDM10 C7orf25 RBL2 DYRK1A HIPK2	1.16e-05	172	67	6	7073_DN
Drug	Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	PRDM10 CD22 MINK1 RBFOX1 DLX2 RYR2	1.98e-05	189	67	6	3165_UP
Drug	Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	PARP11 CD22 MINK1 APAF1 LRP1 DLX2	2.16e-05	192	67	6	4303_UP
Drug	ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A	HIPK3 PHC3 CARF RBFOX1 HIPK2 RYR2	2.23e-05	193	67	6	7490_UP
Drug	Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A	NCOR2 PRDM10 CD22 APAF1 DYRK1A APOBEC1	2.23e-05	193	67	6	3811_UP
Drug	PHA-00851261E [724719-49-7]; Up 200; 10uM; MCF7; HT_HG-U133A	HIVEP3 PARP11 NCOR2 RBL2 DYRK1A DLX2	2.30e-05	194	67	6	3854_UP
Drug	Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	HIVEP3 PARP11 NCOR2 RBL2 APOBEC1 RYR2	2.36e-05	195	67	6	5265_UP
Drug	Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A	PARP11 CARF HIPK2 TCF25 QSER1 ITGB8	2.36e-05	195	67	6	5665_UP
Drug	Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; HL60; HT_HG-U133A	NCOR2 MINK1 RBFOX1 DLX2 QSER1 ASIC4	2.43e-05	196	67	6	2707_UP
Drug	Ioversol [87771-40-2]; Up 200; 5uM; MCF7; HT_HG-U133A	HIPK3 HIVEP3 CD22 APAF1 TRPV4 APOBEC1	2.50e-05	197	67	6	3365_UP
Drug	Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; MCF7; HT_HG-U133A	ZNF280A PTPRM CD22 RBFOX1 TCF25 PAPPA	2.50e-05	197	67	6	6803_UP
Drug	aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A	HIPK3 DLG5 PRDM10 PTPRK APAF1 RFX1	2.50e-05	197	67	6	2664_UP
Drug	Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A	NCOR2 PHC3 CD22 MINK1 APAF1 TCF25	2.57e-05	198	67	6	4812_UP
Drug	Fosfosal [6064-83-1]; Up 200; 18.4uM; HL60; HT_HG-U133A	HIPK3 PTPRM NXPE4 APAF1 TRPV4 APOBEC1	2.72e-05	200	67	6	2997_UP
Drug	halofenate	NCOR1 NCOR2	5.10e-05	4	67	2	CID000033584
Drug	Asbestos, Crocidolite	TRERF1 HIPK3 HIVEP3 NCOR1 PHC3 SYDE2 CARF PAPPA DLX2 SIK3 LYST MED12 SLC25A37	5.69e-05	1241	67	13	ctd:D017638
Drug	Fendiline hydrochloride [13636-18-5]; Up 200; 11.4uM; MCF7; HT_HG-U133A	PTPRM RBFOX1 LRP1 PAPPA DLX2	2.05e-04	183	67	5	3190_UP
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A	HIPK3 PHC3 RBL2 HIPK2 LYST	2.27e-04	187	67	5	4323_DN
Drug	vitamin B	DMGDH NCOR2 APAF1 HIPK2 NUMB TRPV4	2.31e-04	295	67	6	CID000000936
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	HIPK3 HIVEP3 PTPRM APAF1 PAPPA	2.32e-04	188	67	5	5596_UP
Drug	2-oxy	DYRK1A HIPK2	2.36e-04	8	67	2	CID005149739
Drug	Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	HIVEP3 C7orf25 RBFOX1 DYRK1A DLX2	2.44e-04	190	67	5	1483_UP
Drug	Piperacetazine [3819-00-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A	HIPK3 PTPRM RBFOX1 ASIC4 LYST	2.50e-04	191	67	5	3574_UP
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	RBL2 MINK1 NUMB QSER1 RYR2	2.62e-04	193	67	5	1652_UP
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	HIVEP3 HIPK2 CLSTN2 QSER1 RYR2	2.68e-04	194	67	5	3539_DN
Drug	Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	PHC3 DLG5 SVIL HIPK2 QSER1	2.75e-04	195	67	5	4019_DN
Drug	Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A	HIPK3 NCOR2 CD22 RBFOX1 RYR2	2.75e-04	195	67	5	4734_UP
Drug	Clenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A	PTPRM RBFOX1 APAF1 APOBEC1 ASIC4	2.75e-04	195	67	5	5631_UP
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	ZNF280A CD22 HIPK2 MED12 RYR2	2.75e-04	195	67	5	2805_UP
Drug	Ethotoin [86-35-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A	DYRK1A LRP1 TRPV4 APOBEC1 LYST	2.75e-04	195	67	5	6052_UP
Drug	Sulfamerazine [127-79-7]; Down 200; 15.2uM; PC3; HT_HG-U133A	HIPK3 NCOR2 CD22 DLX2 RYR2	2.75e-04	195	67	5	3718_DN
Drug	Boldine [476-70-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	HIVEP3 PHC3 DLG5 PTPRM CLSTN2	2.81e-04	196	67	5	4122_DN
Drug	Cimetidine [51481-61-9]; Down 200; 15.8uM; PC3; HT_HG-U133A	DLG5 CD22 LITAF RBL2 LRP1	2.81e-04	196	67	5	4063_DN
Drug	Nitrendipine [39562-70-4]; Up 200; 11uM; MCF7; HT_HG-U133A	HIPK3 APAF1 DYRK1A CLSTN2 QSER1	2.81e-04	196	67	5	6464_UP
Drug	(R) -Naproxen sodium salt [26159-34-2]; Up 200; 15.8uM; HL60; HT_HG-U133A	HIPK3 PHC3 CARF RBFOX1 APAF1	2.81e-04	196	67	5	2533_UP
Drug	chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A	DYRK1A TRPV4 DLX2 ITGB8 RYR2	2.81e-04	196	67	5	5577_UP
Drug	PF-00539745-00 [351321-33-0]; Down 200; 10uM; MCF7; HT_HG-U133A	NCOR2 PHC3 CD22 MINK1 ASIC4	2.81e-04	196	67	5	5974_DN
Drug	Tridihexethyl chloride; Up 200; 11.4uM; MCF7; HT_HG-U133A	MINK1 PAPPA CLSTN2 LYST SLC25A37	2.81e-04	196	67	5	5486_UP
Drug	PF-00539745-00 [351321-33-0]; Up 200; 10uM; PC3; HT_HG-U133A	NCOR2 APAF1 LRP1 HIPK2 TMEM184C	2.81e-04	196	67	5	5979_UP
Drug	Bezafibrate [41859-67-0]; Up 200; 11uM; MCF7; HT_HG-U133A	MINK1 APAF1 PAPPA DLX2 QSER1	2.88e-04	197	67	5	2630_UP
Drug	novobiocin sodium, USP; Down 200; 100uM; PC3; HG-U133A	PHC3 ATXN2 RBL2 APAF1 LRP1	2.88e-04	197	67	5	435_DN
Drug	Cefalonium [5575-21-3]; Down 200; 8.8uM; MCF7; HT_HG-U133A	MINK1 NUMB DLX2 BCOR SLC25A37	2.88e-04	197	67	5	7341_DN
Drug	Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A	PRDM10 RBL2 APAF1 DYRK1A LYST	2.88e-04	197	67	5	3859_UP
Drug	N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; HL60; HT_HG-U133A	PTPRM MINK1 APAF1 DYRK1A DLX2	2.88e-04	197	67	5	3085_UP
Drug	Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A	MINK1 APAF1 LYST SLC25A37 RYR2	2.88e-04	197	67	5	5317_UP
Drug	Doxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	HIPK3 NCOR1 CD22 MINK1 QSER1	2.88e-04	197	67	5	1473_DN
Drug	Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; HL60; HT_HG-U133A	ZNF280A PHC3 RBFOX1 DYRK1A RYR2	2.88e-04	197	67	5	3004_DN
Drug	Thiorphan [76721-89-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A	ZNF280A HIVEP3 PHC3 MINK1 TRPV4	2.88e-04	197	67	5	2752_UP
Drug	PHA-00745360 [351320-33-7]; Up 200; 1uM; MCF7; HT_HG-U133A	PARP11 APAF1 TCF25 NUMB ASIC4	2.88e-04	197	67	5	3910_UP
Drug	Dihydroergotamine tartrate [5989-77-5]; Up 200; 3uM; MCF7; HT_HG-U133A	HIVEP3 NCOR2 CD22 RBFOX1 DLX2	2.88e-04	197	67	5	6840_UP
Drug	Gelsemine [509-15-9]; Down 200; 12.4uM; PC3; HT_HG-U133A	ZNF280A NCOR2 MINK1 APOBEC1 RYR2	2.88e-04	197	67	5	4097_DN
Drug	Methantheline bromide [53-46-3]; Up 200; 9.6uM; HL60; HT_HG-U133A	HIPK3 DLG5 MINK1 APAF1 RFX1	2.88e-04	197	67	5	6137_UP
Drug	Bezafibrate [41859-67-0]; Up 200; 11uM; PC3; HT_HG-U133A	NCOR2 LRP1 PAPPA APOBEC1 ITGB8	2.88e-04	197	67	5	6653_UP
Drug	Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A	NCOR2 PTPRM RBFOX1 LYST ITGB8	2.88e-04	197	67	5	2779_UP
Drug	Khellin [82-02-0]; Down 200; 15.4uM; PC3; HT_HG-U133A	NCOR2 RBFOX1 LRP1 QSER1 RYR2	2.95e-04	198	67	5	6641_DN
Drug	Tridihexethyl chloride; Up 200; 11.4uM; PC3; HT_HG-U133A	PHC3 APAF1 LRP1 DLX2 RYR2	2.95e-04	198	67	5	5067_UP
Drug	Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A	PHC3 RBFOX1 DYRK1A HIPK2 PAPPA	2.95e-04	198	67	5	3396_UP
Drug	Phensuximide [86-34-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A	ZNF280A PTPRM MINK1 HIPK2 ITGB8	2.95e-04	198	67	5	3521_UP
Drug	Trichlorfon [52-68-6]; Down 200; 15.6uM; HL60; HT_HG-U133A	HIPK3 C7orf25 MINK1 NUMB SIK3	2.95e-04	198	67	5	1839_DN
Drug	HA-1077 dihydrochloride; Down 200; 10uM; PC3; HG-U133A	NCOR2 PHC3 ATXN2 RBL2 SVIL	2.95e-04	198	67	5	436_DN
Drug	Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A	PRDM10 CD22 MINK1 ASIC4 RFX1	2.95e-04	198	67	5	5614_UP
Drug	Pirenperone [ 75444-65-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A	CD22 PAPPA APOBEC1 CLSTN2 ASIC4	2.95e-04	198	67	5	5639_UP
Drug	Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT_HG-U133A	HIVEP3 PHC3 CD22 C7orf25 SVIL	2.95e-04	198	67	5	1299_DN
Drug	Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; HL60; HT_HG-U133A	BNC2 MINK1 RBFOX1 TRPV4 DLX2	2.95e-04	198	67	5	3059_UP
Drug	Lisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; PC3; HT_HG-U133A	NCOR2 PHC3 RBFOX1 LRP1 QSER1	2.95e-04	198	67	5	6682_UP
Drug	Torsemide [56211-40-6]; Down 200; 11.4uM; PC3; HT_HG-U133A	CD22 SVIL HIPK2 NUMB DLX2	3.02e-04	199	67	5	5057_DN
Drug	2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A	HIVEP3 NCOR2 RBFOX1 DYRK1A HIPK2	3.02e-04	199	67	5	2682_DN
Drug	(+,-)-Octopamine hydrochloride [770-05-8]; Up 200; 21uM; PC3; HT_HG-U133A	HIPK3 APAF1 DYRK1A QSER1 ITGB8	3.02e-04	199	67	5	5050_UP
Drug	Trifluridine [70-00-8]; Up 200; 13.6uM; HL60; HT_HG-U133A	ZNF280A DLG5 PRDM10 CARF PAPPA	3.02e-04	199	67	5	6136_UP
Drug	Harpagoside [19210-12-9]; Down 200; 8uM; MCF7; HT_HG-U133A	HIVEP3 DLG5 CLSTN2 SLC25A37 RYR2	3.02e-04	199	67	5	7355_DN
Drug	Nitrocaramiphen hydrochloride; Down 200; 10.8uM; HL60; HT_HG-U133A	HIVEP3 PARP11 CD22 MINK1 TMEM184C	3.02e-04	199	67	5	3125_DN
Drug	Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A	HIVEP3 PHC3 DLG5 MINK1 TCF25	3.02e-04	199	67	5	2257_DN
Drug	Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; HL60; HT_HG-U133A	PRDM10 DLX2 CLSTN2 ASIC4 RYR2	3.02e-04	199	67	5	2388_UP
Drug	Etanidazole [22668-01-5]; Up 200; 18.6uM; MCF7; HT_HG-U133A	HIVEP3 BNC2 PHC3 CARF DLX2	3.02e-04	199	67	5	6072_UP
Drug	Isocarboxazid [59-63-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	NCOR2 PHC3 CD22 ATXN2 APAF1	3.02e-04	199	67	5	3684_DN
Drug	Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	PHC3 CD22 RBFOX1 APAF1 HIPK2	3.02e-04	199	67	5	3169_UP
Drug	Finasteride [98319-26-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	PHC3 MINK1 DLX2 APOBEC1 LYST	3.02e-04	199	67	5	3641_DN
Drug	S-15	TRERF1 CLSTN2	3.03e-04	9	67	2	CID000095656
Drug	tetraiodothyroacetic acid	NCOR1 NCOR2	3.03e-04	9	67	2	ctd:C011126
Drug	CP-320650-01 [172079-28-6]; Up 200; 1uM; PC3; HT_HG-U133A	APAF1 LRP1 PAPPA RFX1 ITGB8	3.09e-04	200	67	5	3825_UP
Drug	Chlorzoxazone [95-25-0]; Up 200; 23.6uM; MCF7; HT_HG-U133A	ZNF280A NCOR2 CD22 QSER1 RYR2	3.09e-04	200	67	5	7456_UP
Drug	AC1L3UEY	NCOR1 NCOR2 RFX1 MED12	3.47e-04	113	67	4	CID000122342
Disease	multiple sclerosis	TET2 NCOR2 SLC9B1 PTPRK ATXN2 SYDE2 SVIL MINK1 CLSTN2	5.25e-06	594	64	9	MONDO_0005301
Disease	intellectual disability (implicated_via_orthology)	ZNF280A RBL2 RBFOX1 DYRK1A	2.18e-05	75	64	4	DOID:1059 (implicated_via_orthology)
Disease	colorectal cancer, endometrial neoplasm	TET2 ATXN2 LITAF	1.05e-04	42	64	3	EFO_0004230, MONDO_0005575
Disease	Colorectal Carcinoma	HIVEP3 TET2 TNNI3K FAT1 LRP1 CLSTN2 IQUB AMTN	1.35e-04	702	64	8	C0009402
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	DMGDH NCOR2 SLC9B1 ATXN2 SIK3	1.73e-04	239	64	5	EFO_0008317, EFO_0020945
Disease	basophil count, eosinophil count	TRERF1 HIVEP3 ATXN2 SIK3 ITGB8	1.80e-04	241	64	5	EFO_0004842, EFO_0005090
Disease	generalised epilepsy	PTPRK RBFOX1 RYR2	1.99e-04	52	64	3	EFO_0005917
Disease	allergic rhinitis	ATXN2 RBFOX1 SIK3 ITGB8	2.03e-04	133	64	4	EFO_0005854
Disease	forced expiratory volume	TET2 DMGDH NCOR1 BNC2 NCOR2 ANGPTL1 ITGB8 RYR2	2.98e-04	789	64	8	EFO_0004314
Disease	event free survival time, type 1 diabetes mellitus, autoantibody measurement	ATXN2 RBFOX1	3.01e-04	12	64	2	EFO_0000482, EFO_0004866, MONDO_0005147
Disease	eosinophil count	TRERF1 HIVEP3 TET2 BNC2 NCOR2 PHC3 ATXN2 LITAF DYRK1A SIK3 ITGB8	3.27e-04	1488	64	11	EFO_0004842
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	TET2 BNC2 TNNI3K PTPRK ATXN2 MINK1 RBFOX1 RYR2	3.29e-04	801	64	8	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	putamen volume change measurement	TAF3 SYDE2	3.56e-04	13	64	2	EFO_0021495
Disease	diastolic blood pressure, systolic blood pressure	BNC2 ATXN2 SVIL RBFOX1 SCYL1 LRP1 RYR2	6.10e-04	670	64	7	EFO_0006335, EFO_0006336
Disease	macula measurement	DLG5 FAT1 NUMB TTK	7.67e-04	189	64	4	EFO_0008375
Disease	serum gamma-glutamyl transferase measurement	DMGDH NCOR2 DLG5 PTPRM LITAF SVIL DYRK1A RYR2	7.85e-04	914	64	8	EFO_0004532
Disease	migraine disorder, Headache	CARF LRP1 PAPPA	8.76e-04	86	64	3	HP_0002315, MONDO_0005277
Disease	visceral adipose tissue measurement, body mass index	RBFOX1 CLSTN2 SIK3	9.06e-04	87	64	3	EFO_0004340, EFO_0004765
Disease	descending aortic diameter	SVIL LRP1 SIK3	9.36e-04	88	64	3	EFO_0021788
Disease	migraine disorder	NCOR2 SVIL CARF LRP1 PAPPA	1.07e-03	357	64	5	MONDO_0005277
Disease	eosinophil percentage of leukocytes	TRERF1 HIVEP3 BNC2 ATXN2 DYRK1A SIK3 ITGB8	1.14e-03	746	64	7	EFO_0007991
Disease	Eczema, allergic rhinitis	BNC2 PTPRK ATXN2 ITGB8	1.24e-03	215	64	4	EFO_0005854, HP_0000964
Disease	risk-taking behaviour	HIVEP3 TET2 BNC2 TNNI3K PTPRM RBFOX1 RYR2	1.31e-03	764	64	7	EFO_0008579
Disease	response to bronchodilator, FEV/FEC ratio	TET2 BNC2 NCOR2 RBFOX1 CLSTN2 SIK3 LYST	1.33e-03	766	64	7	EFO_0004713, GO_0097366
Disease	creatinine measurement	TET2 DMGDH SLC9B1 PRRC2C SVIL NUMB TRPV4 ASIC4	1.35e-03	995	64	8	EFO_0004518
Disease	neutrophil percentage of granulocytes	TRERF1 HIVEP3 ATXN2 ITGB8	1.53e-03	228	64	4	EFO_0007994
Disease	eosinophil percentage of granulocytes	TRERF1 HIVEP3 ATXN2 ITGB8	1.69e-03	234	64	4	EFO_0007996
Disease	right ventricular diastolic volume measurement	ATXN2 RBL2	1.69e-03	28	64	2	EFO_0021814
Disease	eosinophil measurement	ATXN2 DYRK1A ITGB8	1.69e-03	108	64	3	EFO_0803540
Disease	pappalysin‐1 measurement	ATXN2 PAPPA	1.81e-03	29	64	2	EFO_0010618
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	DMGDH NCOR2 ATXN2 SIK3	1.94e-03	243	64	4	EFO_0004612, EFO_0020944

Protein segments in the cluster

Peptide	Gene	Start	Entry
VILQHLVHYTQPELQ	TMEM184C	66	Q9NVA4
QYPAHVSQPANHVTS	ZNF280A	81	P59817
ITQFQRYHQPHTLSP	APAF1	461	O14727
QNCHYQTIPPHILLA	APOBEC1	211	P41238
TQHLYHPTQVEIVQS	BNC2	151	Q6ZN30
VQVVPQHIPNSQQYT	ANGPTL1	216	O95841
VQQQLHPHVLPIFVT	AMTN	91	Q6UX39
THPVQETTFHVAPQQ	DYRK1A	581	Q13627
VNHLIVQPPFLQSVH	CLSTN2	801	Q9H4D0
SHAYPHIQNSKQPRV	BCOR	301	Q6W2J9
QIAASSTYHQHQQPP	DLX2	16	Q07687
LVQPHNVPSIVHSQV	QSER1	346	Q2KHR3
NNPITVQTVYVQHPI	LITAF	71	Q99732
SQNHPVYISPHKNET	RBL2	1051	Q08999
QVHSPVVHVQANSPE	FAT1	2196	Q14517
TQDYTRHHPQQLSAP	NCOR2	2141	Q9Y618
VQHTAYPASIVHQVP	HIPK2	1131	Q9H2X6
PEANVQTQHPHYSRE	EURL	206	Q9NYK6
VVLYHQHKQPEVTNP	LRP1	4136	Q07954
AQQTVFTIHPSHVQP	ATXN2	1221	Q99700
LPTQQAHQYHELETP	CARF	371	Q8N187
EVDEQPQHPLHVTYA	PEBP1	16	P30086
ITILAQYNPHVHQLS	DLG5	1421	Q8TDM6
HVQYATHFPIPQEES	MED12	731	Q93074
IRVQIHSQEEPPYIH	ASIC4	251	Q96FT7
PQPYPQHAIQVQHIQ	PRDM10	971	Q9NQV6
IPVVHDLSQPFYHSQ	PAPPA	1146	Q13219
TYNISHPSGIVHQVP	HIPK3	1151	Q9H422
SYSPIQPHSLIKHQQ	PHC3	296	Q8NDX5
VPYQLIPLHNQTHEY	PARP11	136	Q9NR21
VSPYISIHPERIHNQ	ITGB8	196	P26012
QASHQQPVQYSNPHI	C7orf25	151	Q9BPX7
HSPQSVPVHDIYVSQ	FRRS1	41	Q6ZNA5
LLAVHPPTNTYVCHN	LYST	2016	Q99698
SHVPLYPNSQPQVHL	MS4A8	31	Q9BY19
LEHPLIPVQHQYVVT	DMGDH	261	Q9UI17
EVISPRQVSYTPQHH	IQUB	81	Q8NA54
PQFLQVPSNHEHIEV	RYR2	1256	Q92736
QVQYAPEPSTVQILH	CD22	326	P20273
QHVVNHLPPYTNVSL	PTPRK	451	Q15262
HPQHTITNLSPYTNV	PTPRM	441	P28827
YIPVHIQSQITPHAI	MINK1	1201	Q8N4C8
HQSPSLVRQQTFPHY	NUMB	551	P49757
TNHPPSNLLYQEQHV	FER1L6	811	Q2WGJ9
NPIHPAHSTEFVQQY	SYDE2	441	Q5VT97
EDYIHNIEPVTFPHQ	TAF3	81	Q5VWG9
HTLNLYPPAQTHSEQ	RBFOX1	61	Q9NWB1
RHQPAPVHYVSFQSE	SVIL	331	O95425
DEPTVNTQIFPHVVH	SCYL1	381	Q96KG9
ITIAYGTNNVHPPQH	NXPE4	516	Q6UWF7
QLQQVPVPHVYSSQV	RFX1	281	P22670
YSPESQAQSVHHQRP	NCOR1	2101	O75376
VNPHRTYNPQSHIIS	SLC25A37	226	Q9NYZ2
QQTSNTQPIPILYEH	PRRC2C	2511	Q9Y520
HQQPPHYTTSALQQA	SIK3	936	Q9Y2K2
QATQIVPHQGQYLHP	SHISA2	231	Q6UWI4
AAAHQVQVLPYPFTH	UTP14C	676	Q5TAP6
LHEQVHQGPVPLSYT	RNF44	96	Q7L0R7
PYTEALQVFHHPVAQ	HIVEP3	1116	Q5T1R4
YQNIKPQHYPSIHIT	PREPL	626	Q4J6C6
IRNVPFINEHVHVPN	SLC9B1	136	Q4ZJI4
LAHPYVQIQTHPVNQ	TTK	786	P33981
QQQPHHPQTESVNSY	TET2	1546	Q6N021
VQPHVVNIYGDTPLH	TNNI3K	261	Q59H18
LVTHQVVHTGQRPYP	ZNF425	261	Q6IV72
EPNNIVVLLQTSPYH	TCF25	271	Q9BQ70
NQPHIVNYLTENPHK	TRPV4	296	Q9HBA0
HQYTPEQAHTVQLIP	TRERF1	356	Q96PN7